Testing effectiveness (Phase 2)Ended earlyNCT01418742
What this trial is testing
SKIP - A Double-blind Placebo-controlled Randomized Multicenter Trial of Skin Toxicity Treatment
Who this might be right for
Colorectal Carcinoma
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 11